These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17513707)

  • 1. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity.
    Dyck PJ; Norell JE; Tritschler H; Schuette K; Samigullin R; Ziegler D; Bastyr EJ; Litchy WJ; O'Brien PC
    Diabetes Care; 2007 Oct; 30(10):2619-25. PubMed ID: 17513707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.
    Dyck PJ; O'Brien PC; Litchy WJ; Harper CM; Klein CJ; Dyck PJ
    Diabetes Care; 2005 Sep; 28(9):2192-200. PubMed ID: 16123489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.
    Perkins BA; Grewal J; Ng E; Ngo M; Bril V
    Diabetes Care; 2006 Sep; 29(9):2023-7. PubMed ID: 16936147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whither clinical research in diabetic sensorimotor peripheral neuropathy? Problems of end point selection for clinical trials.
    Boulton AJ
    Diabetes Care; 2007 Oct; 30(10):2752-3. PubMed ID: 17901534
    [No Abstract]   [Full Text] [Related]  

  • 6. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
    J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.
    Davies JL; Lodermeier KA; Klein DM; Carter RE; Dyck PJB; Litchy WJ; Dyck PJ
    Muscle Nerve; 2023 Jul; 68(1):29-38. PubMed ID: 36734298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes.
    Kincaid JC; Price KL; Jimenez MC; Skljarevski V
    Muscle Nerve; 2007 Dec; 36(6):821-7. PubMed ID: 17683081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distal symmetric polyneuropathy in diabetes. Differences between patients with and without neuropathic pain.
    Mondelli M; Aretini A; Baldasseroni A
    Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):45-50. PubMed ID: 21915817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort.
    Dyck PJ; Davies JL; Litchy WJ; O'Brien PC
    Neurology; 1997 Jul; 49(1):229-39. PubMed ID: 9222195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular electrical stimulation for the treatment of diabetic sensorimotor polyneuropathy: A prospective, cohort, proof-of-concept study.
    Smith S; Ravikumar R; Carvalho C; Normahani P; Lane T; Davies AH
    Neurophysiol Clin; 2024 May; 54(3):102943. PubMed ID: 38422719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance analysis of noninvasive electrophysiological methods for the assessment of diabetic sensorimotor polyneuropathy in clinical research: a systematic review and meta-analysis with trial sequential analysis.
    Haque F; Reaz MBI; Ali SHM; Arsad N; Chowdhury MEH
    Sci Rep; 2020 Dec; 10(1):21770. PubMed ID: 33303857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy.
    Polydefkis M; Arezzo J; Nash M; Bril V; Shaibani A; Gordon RJ; Bradshaw KL; Junor RW;
    J Peripher Nerv Syst; 2015 Dec; 20(4):363-71. PubMed ID: 26313450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.